The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121561155 12156115 5 F 2016 20160916 20160307 20160920 EXP BR-JNJFOC-20160303766 JANSSEN 0.00 A M Y 80.00000 KG 20160920 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121561155 12156115 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N UNKNOWN 0 5 DF LYOPHILIZED POWDER
121561155 12156115 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 4 VIALS N UNKNOWN 0 4 DF LYOPHILIZED POWDER
121561155 12156115 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 4 VIALS N UNKNOWN 0 4 DF LYOPHILIZED POWDER
121561155 12156115 4 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) 4 VIALS N UNKNOWN 0 4 DF LYOPHILIZED POWDER
121561155 12156115 5 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N UNKNOWN 0 LYOPHILIZED POWDER
121561155 12156115 6 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) REPORTED AS 4 VIALS N UNKNOWN 103772 4 DF LYOPHILIZED POWDER
121561155 12156115 7 C AZATHIOPRINE. AZATHIOPRINE 1 Unknown D 0 TABLET
121561155 12156115 8 C HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 Unknown D 0 25 MG UNKNOWN
121561155 12156115 9 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown D 0 5 MG UNKNOWN
121561155 12156115 10 C LOSARTAN. LOSARTAN 1 Unknown D 0 50 MG UNKNOWN
121561155 12156115 11 C VITAMIN D3 CHOLECALCIFEROL 1 Unknown D 0 UNSPECIFIED
121561155 12156115 12 C APRESOLINE HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE 1 Unknown D 0 25 MG UNSPECIFIED
121561155 12156115 13 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Unknown D 0 25 MG UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121561155 12156115 1 Crohn's disease
121561155 12156115 2 Crohn's disease
121561155 12156115 3 Crohn's disease
121561155 12156115 4 Crohn's disease
121561155 12156115 5 Crohn's disease
121561155 12156115 6 Crohn's disease
121561155 12156115 7 Crohn's disease
121561155 12156115 8 Hypertension
121561155 12156115 9 Hypertension
121561155 12156115 10 Hypertension

Outcome of event

Event ID CASEID OUTC COD
121561155 12156115 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
121561155 12156115 Drug ineffective
121561155 12156115 Frequent bowel movements
121561155 12156115 Peripheral swelling
121561155 12156115 Sacroiliitis
121561155 12156115 Vitamin B12 decreased
121561155 12156115 Weight fluctuation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121561155 12156115 2 20150622 0
121561155 12156115 3 20150707 0
121561155 12156115 4 20150803 0
121561155 12156115 5 20160119 0
121561155 12156115 6 201605 0
121561155 12156115 7 20160721 0